We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$836M
AUM Growth
+$186M
Cap. Flow
+$173M
Cap. Flow %
20.65%
Top 10 Hldgs %
29.89%
Holding
597
New
223
Increased
13
Reduced
17
Closed
170

Sector Composition

Rank Sector Weight
1 Healthcare 33.03%
2 Financials 12.76%
3 Technology 11.06%
4 Industrials 8.14%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLAT
201
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$968K 0.12%
+99,990
New +$975K
EQHA
202
DELISTED
EQ Health Acquisition Corp.
EQHA
$966K 0.12%
+99,996
New +$976K
TZPS
203
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$917K 0.11%
94,496
-5,500
-6% -$53.7K
PTGX icon
204
Protagonist Therapeutics
PTGX
$9.44B
$898K 0.11%
+20,000
New +$660K
FA icon
205
First Advantage
FA
$4.12B
$896K 0.11%
+45,000
New +$913K
AOMR
206
Angel Oak Mortgage REIT
AOMR
$209M
$894K 0.11%
+50,000
New +$902K
XMTR icon
207
Xometry
XMTR
$5.34B
$874K 0.1%
+10,000
New +$874K
REPX icon
208
Riley Exploration Permian
REPX
$758M
$869K 0.1%
+30,000
New +$1.07M
DLCA
209
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$868K 0.1%
89,682
MCW
210
DELISTED
Mister Car Wash
MCW
$861K 0.1%
+40,000
New +$850K
NDAC
211
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
$848K 0.1%
+86,840
New +$852K
STSA
212
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$832K 0.1%
118,027
-58,030
-33% -$313K
RIDE
213
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$830K 0.1%
5,000
LCIDW
214
DELISTED
Lucid Group, Inc. Warrant
LCIDW
$795K 0.1%
49,998
LOGC
215
DELISTED
ContextLogic
LOGC
$790K 0.09%
+2,000
New +$709K
KDMN
216
DELISTED
Kadmon Holdings, Inc.
KDMN
$774K 0.09%
200,000
FIGS icon
217
FIGS
FIGS
$2.37B
$752K 0.09%
+15,000
New +$561K
AKYA
218
DELISTED
Akoya BioSciences
AKYA
$736K 0.09%
+38,064
New +$786K
HCII
219
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$728K 0.09%
+74,992
New +$737K
FSBC icon
220
Five Star Bancorp
FSBC
$1.13B
$725K 0.09%
+30,000
New +$777K
PDYN icon
221
Palladyne AI
PDYN
$296M
$699K 0.08%
+11,666
New +$695K
FRXB
222
DELISTED
Forest Road Acquisition Corp. II
FRXB
$686K 0.08%
+69,990
New +$686K
PINE
223
Alpine Income Property Trust
PINE
$352M
$666K 0.08%
+35,000
New +$640K
INDT
224
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$657K 0.08%
10,000
-10,000
-50% -$640K
ENVXW
225
DELISTED
Enovix Corporation Warrant
ENVXW
$638K 0.08%
61,970
-528
-0.8% -$2.81K

Similar funds

Monashee Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Monashee Investment Management held 597 positions worth $836M, up 29% from $650M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Monashee Investment Management deployed $173M of net new capital in Q2 2021, opening 223 new positions and adding to 13 existing holdings. Its largest new stake was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Beam Therapeutics, an estimated $13.5M trimmed.

  • Monashee Investment Management's largest Q2 2021 buy was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.
  • Monashee Investment Management added most to PLAYSTUDIOS Inc in Q2 2021, an estimated $14.5M increase.
  • Monashee Investment Management's biggest Q2 2021 reduction was Beam Therapeutics, cutting an estimated $13.5M.
  • Monashee Investment Management fully exited Sotera Health in Q2 2021, selling an estimated $8.74M.
  • Monashee Investment Management's ten largest holdings make up 30% of its $836M portfolio in Q2 2021.
  • Monashee Investment Management opened 223 new positions and closed 170 in Q2 2021.
  • Monashee Investment Management's portfolio value rose 29% quarter-over-quarter to $836M.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.